Angel Pharmaceuticals is a biotech company focused on developing a pipeline of innovative medicines for cancer and autoimmune diseases. Angel Pharmaceuticals was launched with strategic collaboration with U.S. biopharmaceutical company Corvus Pharmaceuticals, Inc., with investments from Puissance Capital, Hisun Pharmaceuticals, Tigermed and fund associated with Betta Pharmaceuticals.

Angel Pharmaceuticals has established research and development facilities in Jiaxing, Zhejiang Province in China, and in Burlingame, California in USA, and assembled a team experienced in clinical development and pre-clinical research.